knowledge -WSS

knowledge

author：Wikipedia 2025-10-02 18:48:39 - browse：632

intarcia implant. -- health tech coverage from STAT — The matchstick-sized, implantable device from Intarcia Therapeutics releases a steady, continuous, and low-dose stream of a drug for diabetes. Stuart Isett/Fortune Brainstorm Health

An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice.

Intarcia called for the panel meeting because of those two rejections, seeking outside input on the FDA’s decision. FDA then granted Intarcia’s request. The agency is not bound to advisory panel decisions, though it tends to follow their advice.

Intarcia started developing its lead therapy, a small, skinny bar implanted under the skin, for type 2 diabetes patients in 2016. The implant delivers a glucose-controlling medicine called exenatide, a member of the GLP-1 drugs that have taken the diabetes and obesity markets by storm. Intarcia’s implant continuously administers the drug over six months, with the goal of improving patient adherence compared to Eli Lilly and Novo Nordisk’s weekly GLP-1 shots.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： The Harvard botanist who searched for psychedelics in the Amazon

WSS

Another man arrested in connection with shooting at Kansas nightclub

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

Community Health Systems hospitals under DOJ investigation

New documents shed light on MD Anderson Cancer Institute feud

Neutralizing antibodies against HIV shows promise in children

hotspot

knowledge

Wikipedia

Peter Hotez and the public health issue of online harassment

NIH study of ME/CFS points to clear biological hallmarks

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

6 phony surgeries that take placebo to the extreme

ChatGPT in medicine: STAT answers readers' burning questions

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Activists slam private health insurers over coverage restrictions

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Apple is now the first public company to be valued at $3 trillion

Neutralizing antibodies against HIV shows promise in children

explore

What to know about a major upcoming Wegovy heart health study

House panel to mark up pandemic

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

6 phony surgeries that take placebo to the extreme

focus

explore

entertainment

leisure time